Sol-Gel Technologies Ltd. (SLGL)
NASDAQ
SLGL price, last 12 months
Key stats
- Previous close
- $53.36
- Open
- $53.72
- Day range
- $53.38 – $55.32
- 52-week range
- $34.10 – $97.97
- Volume
- 45K
- Avg volume (20 days)
- 37.9K
- Market cap
- $180.5M
Performance
Technicals and fundamentals
About Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted. It generates the majority of its revenue from the United States.
- Listed on
- NASDAQ
- Market cap
- $180.5M